stockrowANI Pharmaceuticals, Inc. (ANIP) vs Perrigo Company plc (PRGO)
- ANI Pharmaceuticals, Inc. ANIP 69.03 −3.66%
- Perrigo Company plc PRGO 15.66 −1.07%
ANI Pharmaceuticals, Inc. and Perrigo Company plc are both Drug Manufacturers Specialty & Generic companies. Perrigo Company plc is the larger, with a market value of $2.2B against $1.6B — 1.4× the size. Perrigo Company plc has negative trailing earnings, so its P/E is not meaningful; ANI Pharmaceuticals, Inc. trades at 13.3×. ANI Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 25.9% against −4.47%. ANI Pharmaceuticals, Inc. has the higher net margin (11.2% vs −43.3%) and the higher return on invested capital (46.4% vs −19.0%). Across the 19 metrics below, ANI Pharmaceuticals, Inc. leads on 15 and Perrigo Company plc on 4.
Valuation
Profitability
| Metric | ANIP | PRGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 61.06% | 32.33% | 53.51% |
| Operating margin | 15.99% | (39.43%) | 0.00% |
| Net margin | 11.22% | (43.27%) | (2.45%) |
| Free cash flow margin | 19.72% | 4.11% | 0.00% |
| Return on equity | 20.45% | (51.39%) | (0.80%) |
| Return on assets | 7.85% | (20.15%) | (1.67%) |
| Return on invested capital | 46.43% | (19.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack